{"id":23706,"date":"2023-05-26T11:32:25","date_gmt":"2023-05-26T09:32:25","guid":{"rendered":"https:\/\/www.certest.es\/?p=23706"},"modified":"2023-05-26T11:40:35","modified_gmt":"2023-05-26T09:40:35","slug":"desarrollo-de-una-vacuna-de-mrna-frente-a-la-tuberculosis","status":"publish","type":"post","link":"https:\/\/www.certest.es\/es\/news\/desarrollo-de-una-vacuna-de-mrna-frente-a-la-tuberculosis\/","title":{"rendered":"Desarrollo de una vacuna de mRNA frente a la tuberculosis"},"content":{"rendered":"<h2>Certest Biotec, la Universidad de Zaragoza y la Universidad del Pa\u00eds Vasco trabajan en el desarrollo de una nueva vacuna inhalada, como refuerzo de la actual y futuras vacunas contra la tuberculosis.<\/h2>\n<p>Certest Biotec, empresa biotecnol\u00f3gica aragonesa, lidera un consorcio formado junto a la Universidad de Zaragoza y la Universidad del Pa\u00eds Vasco (UPV\/EHU) para llevar a cabo un proyecto de investigaci\u00f3n con el objetivo de <span style=\"color: #004f95;\"><strong>desarrollar una vacuna de mRNA frente a la tuberculosis,<\/strong> <\/span>como refuerzo de la actual y futuras vacunas. Esta iniciativa tiene lugar en el marco de proyectos colaborativos de I+D+i orientados a la Medicina Personalizada y Terapias Avanzadas, una actuaci\u00f3n conjunta por parte del Centro para el Desarrollo Tecnol\u00f3gico Industrial y el Instituto de Salud Carlos III, los cuales han seleccionado este proyecto para su cofinanciaci\u00f3n.<\/p>\n<p><img decoding=\"async\" class=\" wp-image-23710 alignleft\" src=\"https:\/\/www.certest.es\/wp-content\/uploads\/2023\/05\/Vacuna-tuberculosis-img-post-1.png\" alt=\"\" width=\"517\" height=\"327\" srcset=\"https:\/\/www.certest.es\/wp-content\/uploads\/2023\/05\/Vacuna-tuberculosis-img-post-1-200x126.png 200w, https:\/\/www.certest.es\/wp-content\/uploads\/2023\/05\/Vacuna-tuberculosis-img-post-1-300x190.png 300w, https:\/\/www.certest.es\/wp-content\/uploads\/2023\/05\/Vacuna-tuberculosis-img-post-1-320x202.png 320w, https:\/\/www.certest.es\/wp-content\/uploads\/2023\/05\/Vacuna-tuberculosis-img-post-1-400x253.png 400w, https:\/\/www.certest.es\/wp-content\/uploads\/2023\/05\/Vacuna-tuberculosis-img-post-1.png 593w\" sizes=\"(max-width: 517px) 100vw, 517px\" \/><\/p>\n<p>El proyecto cuenta con 1.4 millones de euros y su objetivo es desarrollar una nueva vacuna inhalada de RNA frente a <em>Mycobacterium tuberculosis,<\/em> el agente causal de la tuberculosis, la enfermedad infecciosa que m\u00e1s muertes ha causado al a\u00f1o en el mundo durante siglos (1.6 millones de muertes en 2021). Esto es debido, entre otros factores, a que actualmente la \u00fanica vacuna disponible tiene una eficacia muy reducida contra la forma m\u00e1s contagiosa de la enfermedad, la tuberculosis pulmonar.<\/p>\n<p>Para acometer este reto se cuenta con la <strong><span style=\"color: #004f95;\">tecnolog\u00eda de vacunas de RNA,<\/span><\/strong> utilizada de manera exitosa y en un tiempo r\u00e9cord para el control de la pandemia mundial del COVID-19. <span style=\"color: #004f95;\"><strong>Este proyecto lograr\u00e1 obtener la primera vacuna de RNA inhalada a nivel mundial en formato liofilizado, resolviendo el problema asociado al transporte y conservaci\u00f3n a temperatura ambiente,<\/strong><\/span> y optimizando su vez la administraci\u00f3n, dirigi\u00e9ndola al pulm\u00f3n y potenciando su acci\u00f3n inmunitaria.<\/p>\n<p>La viabilidad de este innovador proyecto est\u00e1 asegurada gracias a la excelencia y capacidad de cada uno de los socios del consorcio formado. <span style=\"color: #004f95;\"><strong>Certest, para producir esta vacuna de RNA, se encuentra en una posici\u00f3n inmejorable y sin comparaci\u00f3n en Espa\u00f1a, ya que gracias a su intenso trabajo durante los \u00faltimos a\u00f1os cuenta con todos los elementos tecnol\u00f3gicos necesarios para dise\u00f1ar, sintetizar y formular el mRNA en nanopart\u00edculas lip\u00eddicas. <\/strong><\/span>Por parte de la Universidad de Zaragoza se aporta la experiencia en vacunas contra tuberculosis y las instalaciones de seguridad microbiol\u00f3gica para el trabajo con el pat\u00f3geno causante de la enfermedad. A su vez, el grupo NanoBioCel de la UPV\/EHU cuenta con una amplia experiencia en la formulaci\u00f3n y caracterizaci\u00f3n de composiciones farmac\u00e9uticas y, en concreto, formulaciones para administraci\u00f3n pulmonar, contando con laboratorios y equipamiento de \u00faltima generaci\u00f3n que pertenecen a la Unidad U10 Drug Formulation de Nanbiosis, infraestructura de investigaci\u00f3n reconocida por el Ministerio de Ciencia e Innovaci\u00f3n como Infraestructura Cient\u00edfico-Tecnol\u00f3gica Singular (ICTS).<\/p>\n<p><span style=\"color: #004f95;\"><strong>Este proyecto podr\u00eda tener un gran impacto en la salud y bienestar de la sociedad a nivel global, permitiendo salvar millones de vidas a trav\u00e9s de la universalizaci\u00f3n de una vacuna termoestable y de bajo coste frente a la enfermedad infecciosa que m\u00e1s muertes provoca del mundo.<\/strong><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Certest Biotec, la Universidad de Zaragoza y la Universidad del  [&#8230;]<\/p>\n","protected":false},"author":7,"featured_media":23712,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[23,1],"tags":[113,121,2450,2435,2381,2449,2455,2119,2218],"class_list":["post-23706","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-destacadas","category-noticias","tag-certest","tag-health","tag-international-es","tag-pharma-es","tag-spain-es","tag-terapeutico","tag-therapeutics-es","tag-vaccine-es","tag-vaccines-es"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Desarrollo de una vacuna de mRNA frente a la tuberculosis - Certest Biotec - Raw Materials | Diagnostics | Pharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.certest.es\/news\/development-of-an-mrna-vaccine-against-tuberculosis\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Desarrollo de una vacuna de mRNA frente a la tuberculosis - Certest Biotec - Raw Materials | Diagnostics | Pharma\" \/>\n<meta property=\"og:description\" content=\"Certest Biotec, la Universidad de Zaragoza y la Universidad del [...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.certest.es\/news\/development-of-an-mrna-vaccine-against-tuberculosis\/\" \/>\n<meta property=\"og:site_name\" content=\"Certest Biotec - Raw Materials | Diagnostics | Pharma\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-26T09:32:25+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-05-26T09:40:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.certest.es\/wp-content\/uploads\/2023\/05\/2023_05_26_Vacuna-tuberculosis-img.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"700\" \/>\n\t<meta property=\"og:image:height\" content=\"403\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Certest\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Certest\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.certest.es\/news\/development-of-an-mrna-vaccine-against-tuberculosis\/\",\"url\":\"https:\/\/www.certest.es\/news\/development-of-an-mrna-vaccine-against-tuberculosis\/\",\"name\":\"Desarrollo de una vacuna de mRNA frente a la tuberculosis - Certest Biotec - Raw Materials | Diagnostics | Pharma\",\"isPartOf\":{\"@id\":\"https:\/\/www.certest.es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.certest.es\/news\/development-of-an-mrna-vaccine-against-tuberculosis\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.certest.es\/news\/development-of-an-mrna-vaccine-against-tuberculosis\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.certest.es\/wp-content\/uploads\/2023\/05\/2023_05_26_Vacuna-tuberculosis-img.jpg\",\"datePublished\":\"2023-05-26T09:32:25+00:00\",\"dateModified\":\"2023-05-26T09:40:35+00:00\",\"author\":{\"@id\":\"https:\/\/www.certest.es\/#\/schema\/person\/50c59c84a6cb9d30c27518b73f47b617\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.certest.es\/news\/development-of-an-mrna-vaccine-against-tuberculosis\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.certest.es\/news\/development-of-an-mrna-vaccine-against-tuberculosis\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.certest.es\/news\/development-of-an-mrna-vaccine-against-tuberculosis\/#primaryimage\",\"url\":\"https:\/\/www.certest.es\/wp-content\/uploads\/2023\/05\/2023_05_26_Vacuna-tuberculosis-img.jpg\",\"contentUrl\":\"https:\/\/www.certest.es\/wp-content\/uploads\/2023\/05\/2023_05_26_Vacuna-tuberculosis-img.jpg\",\"width\":700,\"height\":403,\"caption\":\"Vaccines technology\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.certest.es\/news\/development-of-an-mrna-vaccine-against-tuberculosis\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/www.certest.es\/es\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Desarrollo de una vacuna de mRNA frente a la tuberculosis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.certest.es\/#website\",\"url\":\"https:\/\/www.certest.es\/\",\"name\":\"Certest Biotec - Raw Materials | Diagnostics | Pharma\",\"description\":\"Productos para diagn\u00f3stico in vitro\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.certest.es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.certest.es\/#\/schema\/person\/50c59c84a6cb9d30c27518b73f47b617\",\"name\":\"Certest\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Desarrollo de una vacuna de mRNA frente a la tuberculosis - Certest Biotec - Raw Materials | Diagnostics | Pharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.certest.es\/news\/development-of-an-mrna-vaccine-against-tuberculosis\/","og_locale":"es_ES","og_type":"article","og_title":"Desarrollo de una vacuna de mRNA frente a la tuberculosis - Certest Biotec - Raw Materials | Diagnostics | Pharma","og_description":"Certest Biotec, la Universidad de Zaragoza y la Universidad del [...]","og_url":"https:\/\/www.certest.es\/news\/development-of-an-mrna-vaccine-against-tuberculosis\/","og_site_name":"Certest Biotec - Raw Materials | Diagnostics | Pharma","article_published_time":"2023-05-26T09:32:25+00:00","article_modified_time":"2023-05-26T09:40:35+00:00","og_image":[{"width":700,"height":403,"url":"https:\/\/www.certest.es\/wp-content\/uploads\/2023\/05\/2023_05_26_Vacuna-tuberculosis-img.jpg","type":"image\/jpeg"}],"author":"Certest","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Certest","Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.certest.es\/news\/development-of-an-mrna-vaccine-against-tuberculosis\/","url":"https:\/\/www.certest.es\/news\/development-of-an-mrna-vaccine-against-tuberculosis\/","name":"Desarrollo de una vacuna de mRNA frente a la tuberculosis - Certest Biotec - Raw Materials | Diagnostics | Pharma","isPartOf":{"@id":"https:\/\/www.certest.es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.certest.es\/news\/development-of-an-mrna-vaccine-against-tuberculosis\/#primaryimage"},"image":{"@id":"https:\/\/www.certest.es\/news\/development-of-an-mrna-vaccine-against-tuberculosis\/#primaryimage"},"thumbnailUrl":"https:\/\/www.certest.es\/wp-content\/uploads\/2023\/05\/2023_05_26_Vacuna-tuberculosis-img.jpg","datePublished":"2023-05-26T09:32:25+00:00","dateModified":"2023-05-26T09:40:35+00:00","author":{"@id":"https:\/\/www.certest.es\/#\/schema\/person\/50c59c84a6cb9d30c27518b73f47b617"},"breadcrumb":{"@id":"https:\/\/www.certest.es\/news\/development-of-an-mrna-vaccine-against-tuberculosis\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.certest.es\/news\/development-of-an-mrna-vaccine-against-tuberculosis\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.certest.es\/news\/development-of-an-mrna-vaccine-against-tuberculosis\/#primaryimage","url":"https:\/\/www.certest.es\/wp-content\/uploads\/2023\/05\/2023_05_26_Vacuna-tuberculosis-img.jpg","contentUrl":"https:\/\/www.certest.es\/wp-content\/uploads\/2023\/05\/2023_05_26_Vacuna-tuberculosis-img.jpg","width":700,"height":403,"caption":"Vaccines technology"},{"@type":"BreadcrumbList","@id":"https:\/\/www.certest.es\/news\/development-of-an-mrna-vaccine-against-tuberculosis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/www.certest.es\/es\/"},{"@type":"ListItem","position":2,"name":"Desarrollo de una vacuna de mRNA frente a la tuberculosis"}]},{"@type":"WebSite","@id":"https:\/\/www.certest.es\/#website","url":"https:\/\/www.certest.es\/","name":"Certest Biotec - Raw Materials | Diagnostics | Pharma","description":"Productos para diagn\u00f3stico in vitro","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.certest.es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/www.certest.es\/#\/schema\/person\/50c59c84a6cb9d30c27518b73f47b617","name":"Certest"}]}},"_links":{"self":[{"href":"https:\/\/www.certest.es\/es\/wp-json\/wp\/v2\/posts\/23706","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.certest.es\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.certest.es\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.certest.es\/es\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.certest.es\/es\/wp-json\/wp\/v2\/comments?post=23706"}],"version-history":[{"count":0,"href":"https:\/\/www.certest.es\/es\/wp-json\/wp\/v2\/posts\/23706\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.certest.es\/es\/wp-json\/wp\/v2\/media\/23712"}],"wp:attachment":[{"href":"https:\/\/www.certest.es\/es\/wp-json\/wp\/v2\/media?parent=23706"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.certest.es\/es\/wp-json\/wp\/v2\/categories?post=23706"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.certest.es\/es\/wp-json\/wp\/v2\/tags?post=23706"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}